欢迎来到联参智库! | 帮助中心 联合作战情报参考网
联参智库

R45069_

Drug Compounding: FDA Authority and Possible Issues for Congress name redacted Analyst in Health Policy January 5, 2018,

R45069_Tag内容描述:

1、 Drug Compounding: FDA Authority and Possible Issues for Congress name redacted Analyst in Health Policy January 5, 2018。

【R45069_】相关PDF文档
[20180105]R45069_药物配制:FDA授权和国会可能面临的问题 .pdf
1

客服:010-66465788   北京联参科技有限公司版权所有  工业和信息化部备案/许可证编号:京ICP备2022007273号-1



联参智库